Dr. Anteneh Tesema, MD

Dr. Tesema practices at MultiCare Covington Medical Center in Covington, Washington, part of MultiCare Health System.

Dr. Tesema's NPI, 1760914089, was assigned on March 28, 2017. Dr. Tesema holds Washington license 61260762.

Dr. Tesema's primary practice is MultiCare Covington Medical Center, at 17700 Se 272nd St, Covington, WA 98042 in King County. The practice phone is (253) 372-7400.

Dr. Tesema's primary practice is MultiCare Covington Medical Center in Covington, Washington, part of MultiCare Health System. Dr. Tesema is also affiliated with MultiCare Tacoma General Hospital. The medical group on file is Virginia Mason Medical Center. Dmand AI also links Dr. Tesema to 3 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tesema practices, 6 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Tesema's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Tesema's licenses on file in 2 states: Washington and Tennessee.

CMS data shows 816 Medicare services from Dr. Tesema across 6 procedure codes in 2024, for 319 Medicare patients. Medicare paid $65,282 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 319 Medicare patients who saw Dr. Tesema in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tesema's median patient age at 73, with 58% women.

In 2024, Dr. Tesema wrote 389 Medicare Part D claims for 203 patients. 86% of them were for generic drugs. CMS names the drug for 163 of them, across 9 drugs with 11 or more claims each, at $10,506 in total drug cost. In 2023, CMS named 115 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Tesema for performance year 2024, reported as part of a group. Dr. Tesema accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 14 general payments to Dr. Tesema from 5 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $109.